Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 2435  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission

    Article Cited by others


Recent advances in gene therapy for thalassemia

Raja J V, Rachchh M A, Gokani R H

Year : 2012| Volume: 4| Issue : 3 | Page no: 194-201

   This article has been cited by
1 PLGA-Nanoparticles for Intracellular Delivery of the CRISPR-Complex to Elevate Fetal Globin Expression in Erythroid Cells
Luis J. Cruz, Thamar van Dijk, Olena Vepris, Tracy M.W.Y. Li, Timo Schomann, Fabio Baldazzi, Ryo Kurita, Yukio Nakamura, Frank Grosveld, Sjaak Philipsen, Christina Eich
Biomaterials. 2021; 268: 120580
[Pubmed]  [Google Scholar] [DOI]
2 From non-invasive to invasive fetal therapy: A comprehensive review and current update
Tzu-Yi Lin, Tuangsit Wataganara, Steven W. Shaw
Taiwanese Journal of Obstetrics and Gynecology. 2021; 60(4): 595
[Pubmed]  [Google Scholar] [DOI]
3 CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells
Xie Yingjun, Xie Yuhuan, Chen Yuchang, Li Dongzhi, Wang Ding, Song Bing, Yang Yi, Lu Dian, Xue Yanting, Xiong Zeyu, Liu Nengqing, Chen Diyu, Sun Xiaofang
Annals of Hematology. 2019; 98(12): 2661
[Pubmed]  [Google Scholar] [DOI]
4 Management of Children With -Thalassemia Intermedia: Overview, Recent Advances, and Treatment Challenges
Amira A. Adly, Eman A. Ismail
Journal of Pediatric Hematology/Oncology. 2018; 40(4): 253
[Pubmed]  [Google Scholar] [DOI]
5 Revisiting beta thalassemia intermedia: past, present, and future prospects
Naouel Ben Salah,Rayan Bou-Fakhredin,Fethi Mellouli,Ali T. Taher
Hematology. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
6 Haemoglobin disorders in Australia: where are we now and where will we be in the future?
G. Crighton,E. Wood,R. Scarborough,P. J. Ho,D. Bowden
Internal Medicine Journal. 2016; 46(7): 770
[Pubmed]  [Google Scholar] [DOI]
7 Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and -thalassemia
Lin Ye,Jiaming Wang,Yuting Tan,Ashley I. Beyer,Fei Xie,Marcus O. Muench,Yuet Wai Kan
Proceedings of the National Academy of Sciences. 2016; : 201612075
[Pubmed]  [Google Scholar] [DOI]
8 To study the haemoglobinopathies and ratio of copper and zinc in Sindhi Community of Bhopal
Kaur, M. and Dangi, C.B.S. and Singh, H.
International Journal of Pharma and Bio Sciences. 2013; 4(1): 672-691
[Pubmed]  [Google Scholar]
9 Gene therapy, science fiction or science fact?
Nevine Bahaa E. Soliman
The Egyptian Journal of Histology. 2013; 36(3): 515
[Pubmed]  [Google Scholar] [DOI]


Read this article